Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-EN Version v5-EN
Language English English
Date Updated 2018-06-04 2018-05-11
Drug Identification Number 02240693 02240693
Brand name INTRON A INTRON A
Common or Proper name interferon alfa-2b solution for injection (multi-dose pen) interferon alfa-2b solution for injection (multi-dose pen)
Company Name MERCK CANADA INC MERCK CANADA INC
Ingredients INTERFERON ALFA-2B INTERFERON ALFA-2B
Strength(s) 15000000UNIT 15000000UNIT
Dosage form(s) LIQUID LIQUID
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 18MIU 18MIU
ATC code L03AB L03AB
ATC description IMMUNOSTIMULANTS IMMUNOSTIMULANTS
Reason for shortage Requirements related to complying with good manufacturing practices. Requirements related to complying with good manufacturing practices.
Anticipated start date 2018-05-10 2018-05-10
Actual start date 2018-05-10 2018-05-10
Estimated end date 2018-06-08 2018-06-29
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments